VCM
PRAX icon

Versant Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Versant Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670 Hold
2
– – ﹤0.01% 2679
2026
Q1 		$644 Buy
+2
New +$619 ﹤0.01% 2703

Other funds holding PRAX

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EFA
Englebert Financial Advisers Allentown, Pennsylvania $102M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management's PRAX Position: Q2 2026 in Review

Versant Capital Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 2 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #2679.

Versant Capital Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Versant Capital Management held 2 shares of Praxis Precision Medicines worth $670 as of Q2 2026.
  • Versant Capital Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2679 holding.
  • Versant Capital Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.